Apoptosis in prostatic adenocarcinomas; A study of relationship to Ki-67 and bcl-2 protein expression

被引:0
|
作者
Tanji, N [1 ]
Yokoyama, M
Sugamoto, T
Takeuchi, M
Terada, N
机构
[1] Ehime Univ, Sch Med, Dept Urol, Shigenobu, Ehime 79102, Japan
[2] Hyogo Coll Med, Dept Pathol 1, Nishinomiya, Hyogo 663, Japan
关键词
prostatic cancer; apoptosis; Ki-67; Bcl-2;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Tissue samples from patients with prostatic adenocarcinoma (PCA) were examined for relationship between apoptosis and expression of Ki-67 and bcl-2 protein. Materials and Methods: Prostatic tissue was obtained from 29 prostatic cancer patients with no prior therapy. The number of apoptotic cells (apoptotic index; AI) and the percentage of Ki-67 stained cells (Ki-67 labeling index; LI) were compared with the expression of bcl-2 which was evaluated by the proportion and intensity of tumor cell immunostaining. Results: Both AI and LI of moderately and poorly differentiated PCAs were significantly higher than those of well differentiated PCAs. There was a significant correlation between AI and LI. Bcl-2 protein was expressed less in moderately and poorly differentiated PCAs than in well differentiated PCAs. Moreover, there was no correlation between the bcl-2 protein expression and the AI. Conclusions: The results suggest that, in PCAs, the degree of apoptosis is correlated with the cellular proliferation, and that expression of bcl-2 protein is not a critical factor that determines the degree of apoptosis.
引用
收藏
页码:1111 / 1116
页数:6
相关论文
共 50 条
  • [21] Ki-67 and Bcl-2 in colorectal polyps with breast cancer
    Gelincik, Ibrahim
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2011, 54 (02) : 307 - 311
  • [22] Immunohistochemical expression of Bcl-2, Ki-67, and p21 in patients with papillary thyroid cancer - Increased Ki-67 expression in older patients
    Siironen, P
    Nordling, S
    Louhimo, J
    Haapiainen, R
    Haglund, C
    [J]. TUMOR BIOLOGY, 2005, 26 (01) : 50 - 56
  • [23] Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: Diagnostic and histogenetic implications
    Risberg, B
    Karlsson, K
    Abeler, V
    Lagrelius, A
    Davidson, B
    Karlsson, MG
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2002, 21 (02) : 155 - 160
  • [24] Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma
    Ilmonen, S
    Hernberg, M
    Pyrhönen, S
    Tarkkanen, J
    Asko-Seljavaara, S
    [J]. MELANOMA RESEARCH, 2005, 15 (05) : 375 - 381
  • [25] Ki-67, p53, and bcl-2 expression of serrated adenomas of the colon
    Kang, M
    Mitomi, H
    Sada, M
    Tokumitsu, Y
    Takahashi, Y
    Igarashi, M
    Katsumata, T
    Okayasu, I
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (04) : 417 - 423
  • [26] Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis
    Maia, H
    Maltez, A
    Studart, E
    Athayde, C
    Couthino, EM
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2005, 20 (03) : 127 - 131
  • [27] Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers
    Chang, CH
    Tsai, RK
    Chen, GS
    Yu, HS
    Chai, CY
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 1998, 25 (09) : 457 - 462
  • [28] Investigation of the Bcl-2 and C-myc expression in relationship to the Ki-67 labelling index in cervical intraepithelial neoplasia
    Dellas, A
    Schultheiss, E
    Holzgreve, W
    Oberholzer, M
    Torhorst, J
    Gudat, F
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1997, 16 (03) : 212 - 218
  • [29] Ki-67, p53, and Bcl-2 expression in nasopharyngeal carcinoma expression and association with prognosis
    Ben-Izhak, O
    Gov-Ari, E
    Joachims, HZ
    Sabo, E
    Kuten, A
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 215A - 215A
  • [30] Ki-67, p53, and Bcl-2 expression in nasopharyngeal carcinoma expression and association with prognosis
    Ben-Izhak, O
    Gov-Ari, E
    Joachims, HZ
    Sabo, E
    Kuten, A
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 215A - 215A